https://www.selleckchem.com/pr....oducts/blasticidin-s
Montelukast preconditioning offset the up-regulation of transient receptor potential vanilloid 4 (TRPV4) in urothelial tissue of CPA-treated rats, to greater extent than MESNA. These results demonstrate the uroprotective effect of montelukast on CPA-induced HC, which appears to be more superior to MESNA. These findings suggest that montelukast can emerge as a novel strategy to protect against CPA-induced urotoxicity. These results demonstrate the uroprotective effect of montelukast on CPA-induced HC, which appears to be more s